Bayesian Model Assessment in Joint Modeling of Longitudinal and Survival Data With Applications to Cancer Clinical Trials
暂无分享,去创建一个
[1] John Bryant,et al. Bayesian Model Specification , 2018, Bayesian Demographic Estimation and Forecasting.
[2] Joseph Boudreau,et al. Monte Carlo Methods , 2018, Randomization, Bootstrap and Monte Carlo Methods in Biology.
[3] Gang Li,et al. Joint Modeling of Longitudinal and Time-to-Event Data , 2016 .
[4] Wei Shen,et al. JMFit: A SAS Macro for Joint Models of Longitudinal and Survival Data. , 2016, Journal of statistical software.
[5] K. Abrams,et al. Joint Modeling of Longitudinal and Survival Data , 2016 .
[6] John L. Perry,et al. Assessing Model Fit: Caveats and Recommendations for Confirmatory Factor Analysis and Exploratory Structural Equation Modeling , 2015 .
[7] Wei Shen,et al. Assessing model fit in joint models of longitudinal and survival data with applications to cancer clinical trials , 2014, Statistics in medicine.
[8] B. Movsas,et al. Patient-reported outcomes and survivorship in radiation oncology: overcoming the cons. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[9] Arti Shukla,et al. Malignant Mesothelioma: Development to Therapy , 2014, Journal of cellular biochemistry.
[10] Ari Gnanasakthy,et al. Assessment of PRO label claims granted by the FDA as compared to the EMA (2006-2010). , 2013, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[11] Maral Saadati,et al. Joint Models for Longitudinal and Time-to-Event Data with Applications in R. Dimitris Rizopoulos (2012). Boca Raton: Chapman & Hall/CRC Texts in Statistical Science Series. 261 pages, ISBN: 978-1439872864. , 2013 .
[12] Michael J. Crowther,et al. STJM11: Stata module to fit shared parameter joint models of longitudinal and survival data , 2012 .
[13] John F P Bridges,et al. Patients' preferences for treatment outcomes for advanced non-small cell lung cancer: a conjoint analysis. , 2012, Lung cancer.
[14] D. Rizopoulos. Event Time Event Time , 2012 .
[15] Dimitris Rizopoulos,et al. Joint Models for Longitudinal and Time-to-Event Data: With Applications in R , 2012 .
[16] Ping Wang,et al. Joint modeling of longitudinal outcomes and survival using latent growth modeling approach in a mesothelioma trial , 2012, Health Services and Outcomes Research Methodology.
[17] Bradley P. Carlin,et al. Multilevel Bayesian Models for Survival Times and Longitudinal Patient-Reported Outcomes With Many Zeros , 2012 .
[18] Peter J. Diggle,et al. joineR: Joint modelling of repeated measurements and time-to-event data , 2012 .
[19] Bradley P Carlin,et al. Joint Modeling of Multiple Longitudinal Patient-Reported Outcomes and Survival , 2011, Journal of biopharmaceutical statistics.
[20] Joseph G Ibrahim,et al. Basic concepts and methods for joint models of longitudinal and survival data. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[21] Pennifer Erickson,et al. Use of existing patient-reported outcome (PRO) instruments and their modification: the ISPOR Good Research Practices for Evaluating and Documenting Content Validity for the Use of Existing Instruments and Their Modification PRO Task Force Report. , 2009, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[22] Yueh-Yun Chi,et al. Bayesian approaches to joint longitudinal and survival models accommodating both zero and nonzero cure fractions , 2007 .
[23] U. S. D. O. H. A. H. S. F. C. Research,et al. Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims: draft guidance , 2006, Health and quality of life outcomes.
[24] Joseph G Ibrahim,et al. Joint Models for Multivariate Longitudinal and Multivariate Survival Data , 2006, Biometrics.
[25] J. Ibrahim,et al. A Flexible B‐Spline Model for Multiple Longitudinal Biomarkers and Survival , 2005, Biometrics.
[26] Joseph G. Ibrahim,et al. Bayesian Survival Analysis , 2004 .
[27] Joseph G. Ibrahim,et al. A new joint model for longitudinal and survival data with a cure fraction , 2004 .
[28] Joseph G. Ibrahim,et al. BAYESIAN METHODS FOR JOINT MODELING OF LONGITUDINAL AND SURVIVAL DATA WITH APPLICATIONS TO CANCER VACCINE TRIALS , 2004 .
[29] Joseph G Ibrahim,et al. Bayesian Approaches to Joint Cure‐Rate and Longitudinal Models with Applications to Cancer Vaccine Trials , 2003, Biometrics.
[30] U. Gatzemeier,et al. Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[31] Marie Davidian,et al. An estimator for the proportional hazards model with multiple longitudinal covariates measured with error. , 2002, Biostatistics.
[32] H. Sandler,et al. The joint modeling of a longitudinal disease progression marker and the failure time process in the presence of cure. , 2002, Biostatistics.
[33] Bradley P. Carlin,et al. Bayesian measures of model complexity and fit , 2002 .
[34] W. Michael Conklin,et al. Monte Carlo Methods in Bayesian Computation , 2001, Technometrics.
[35] S L Zeger,et al. The Evaluation of Multiple Surrogate Endpoints , 2001, Biometrics.
[36] R Henderson,et al. Joint modelling of longitudinal measurements and event time data. , 2000, Biostatistics.
[37] N. Laird,et al. Mixture models for the joint distribution of repeated measures and event times. , 1997, Statistics in medicine.
[38] V. DeGruttola,et al. Models for empirical Bayes estimators of longitudinal CD4 counts. , 1996, Statistics in medicine.
[39] S. Chib. Marginal Likelihood from the Gibbs Output , 1995 .
[40] D. Bates,et al. Approximations to the Log-Likelihood Function in the Nonlinear Mixed-Effects Model , 1995 .
[41] V. De Gruttola,et al. Modelling progression of CD4-lymphocyte count and its relationship to survival time. , 1994, Biometrics.
[42] Ming-Hui Chen. Importance-Weighted Marginal Bayesian Posterior Density Estimation , 1994 .
[43] A. Gelfand,et al. Bayesian Model Choice: Asymptotics and Exact Calculations , 1994 .
[44] Yudi Pawitan,et al. Modeling Disease Marker Processes in AIDS , 1993 .
[45] J. Geweke,et al. Bayesian Inference in Econometric Models Using Monte Carlo Integration , 1989 .
[46] S. Geisser,et al. A Predictive Approach to Model Selection , 1979 .
[47] J. Meigs,et al. WHO Technical Report , 1954, The Yale Journal of Biology and Medicine.
[48] Berkeley California Disclaimer,et al. University of California , 1886, The American journal of dental science.
[49] Joseph G. Ibrahim,et al. Assessment of Fit in Longitudinal Data for Joint Models with Applications to Cancer Clinical Trials , 2015 .
[50] J. Ibrahim,et al. Handbook of survival analysis , 2014 .
[51] Joseph Hilbe,et al. Assessment of Fit , 2014 .
[52] C. Legrand. Joint Modeling , 2012, Advanced Survival Models.
[53] F. Ongaro. JOINT MODELS FOR LONGITUDINAL AND TIME-TO-EVENT DATA. A STUDY OF THE INFLUENCE OF THE ASSOCIATION STRUCTURE ON EXPECTED SURVIVAL PROBABILITIES. , 2012 .
[54] Wesley O Johnson,et al. Predictive comparison of joint longitudinal-survival modeling: a case study illustrating competing approaches , 2011, Lifetime data analysis.
[55] Jeremy M G Taylor,et al. Discussion of “Predictive Comparison of Joint Longitudinal-Survival Modeling: A Case Study Illustrating Competing Approaches”, by Hanson, Branscum and Johnson , 2011, Lifetime data analysis.
[56] James J. Rusthoven,et al. Measuring quality of life in patients with pleural mesothelioma using a modified version of the Lung Cancer Symptom Scale (LCSS): psychometric properties of the LCSS-Meso , 2005, Supportive Care in Cancer.
[57] M. Davidian,et al. Joint modelling of longitudinal and time-to-event data: an overview , 2004 .
[58] S. Zeger,et al. Joint analysis of longitudinal data comprising repeated measures and times to events , 2001 .
[59] M D Schluchter,et al. Methods for the analysis of informatively censored longitudinal data. , 1992, Statistics in medicine.
[60] Bruce W. Schmeiser,et al. Overlapping batch means: something for nothing? , 1984, WSC '84.